1. Gene expression profile analysis of ENO1 knockdown in gastric cancer cell line MGC‑803
    Zhigang Huang et al, 2019, Oncology Letters CrossRef
  2. The Anticancer Activity of Monosaccharides: Perspectives and Outlooks
    Niamh McCallum et al, 2024, Cancers CrossRef
  3. Association between genetically proxied glucosamine and risk of cancer and non-neoplastic disease: A Mendelian randomization study
    Yingtong Wu et al, 2024, Frontiers in Genetics CrossRef
  4. Regular Glucosamine Use May Have Different Roles in the Risk of Site-Specific Cancers: Findings from a Large Prospective Cohort
    Fu-Xiao Li et al, 2023, Cancer Epidemiology, Biomarkers & Prevention CrossRef
  5. FoxO Transcription Factors: Applicability as a Novel Immune Cell Regulators and Therapeutic Targets in Oxidative Stress-Related Diseases
    Mi Eun Kim et al, 2022, International Journal of Molecular Sciences CrossRef
  6. Targeting ERK-Hippo Interplay in Cancer Therapy
    Karel Vališ et al, 2020, International Journal of Molecular Sciences CrossRef
  7. FOXO1, a tiny protein with intricate interactions: Promising therapeutic candidate in lung cancer
    Mohammad Ebrahimnezhad et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  8. Beneficial applications of glucosamine
    Khadijeh Jamialahmadi, 2019, Molecular Nutrition: Carbohydrates CrossRef
  9. Alginate-like exopolysaccharides in aerobic granular sludge: A review
    Sasmitha Aulia Zahra et al, 2022, Materials Today: Proceedings CrossRef
  10. Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study
    Guowei Li et al, 2022, European Respiratory Journal CrossRef
  11. Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects
    Mohammad Ebrahimnezhad et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  12. Association between glucosamine use and cancer mortality: A large prospective cohort study
    Jian Zhou et al, 2022, Frontiers in Nutrition CrossRef
  13. Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen
    I. Yu. Torshin et al, 2023, FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology CrossRef